Sanofi’s Translate Bio Buyout Shows Growing Hunger for mRNA Technology
Sanofi’s acquisition of its partner Translate Bio is a clear sign that pharmaceutical companies are…
August 17, 2021 - 5 minutes
mRNA: A New Technology Moving into the Mainstream
Messenger RNA (mRNA) technology is based on the idea that human cells can be used as on-demand factories to develop therapeutic proteins by giving them instructions in the form of mRNA. Although mRNA therapeutics and vaccines could be found in drug development pipelines before Covid-19 emerged, the pandemic suddenly moved the mRNA technology into the limelight.
Now, the world has seen mass vaccinations using mRNA-based vaccines developed by Moderna and Pfizer/BioNTech. But the mRNA technology holds promise for other indications as well, including cancer and rare diseases. Read on to learn how this new technology is moving into the mainstream with an influx of investments and new discoveries.
Show More
Editor's Picks for mRNA technology
- Could mRNA Vaccines Fulfill Their Potential Against Coronavirus?
- The COVID-19 pandemic has driven RNA therapeutics into the mainstream
- EMA Greenlights BioNTech and Pfizer mRNA Vaccine for Covid-19
- Next-Generation mRNA Vaccine Technology Unveiled in Series A Round
- Sanofi’s Translate Bio Buyout Shows Growing Hunger for mRNA Technology
European Biotech Industry Report 2021
This report discusses how the Covid-19 pandemic impacted Europe’s life science industry and covers recent market trends, investments, and collaborations.
Go to ReportLatest mRNA technology Articles
Patent Waiver on Covid-19 Vaccines Splits Opinions in Biotech Industry
Attempts to increase global Covid-19 vaccine coverage with a temporary patent waiver have been met…
June 15, 2021 - 5 minutes
Next-Generation mRNA Vaccine Technology Unveiled in Series A Round
Messenger RNA vaccines have been at the forefront of the global struggle against the Covid-19…
June 1, 2021 - 4 minutes
Sponsored
by Merck
How the Vaccine Industry and Biotechs Can Accelerate Pandemic Responses
The global Covid-19 pandemic has forced us to put our lives on hold, and a…
January 12, 2021 - 6 minutes
EMA Greenlights BioNTech and Pfizer mRNA Vaccine for Covid-19
BioNTech and Pfizer’s Covid-19 vaccine, made from messenger RNA, has become the first of its…
December 22, 2020 - 5 minutes
Swiss and German Team to Develop Inhaled mRNA Coronavirus Treatment
The Swiss antibody specialist Neurimmune and the German RNA biotech Ethris are collaborating to develop…
April 2, 2020 - 3 minutes
Could mRNA Vaccines Fulfill Their Potential Against Coronavirus?
The first vaccine against coronavirus disease could one day be made of mRNA. How is…
March 30, 2020 - 7 minutes
CureVac Receives €80M from EU to Fund Coronavirus Vaccine Amid US Dispute
The German biotech CureVac -- which is developing an mRNA vaccine against coronavirus -- has…
March 17, 2020 - 2 minutes
EU Project Receives €15M to Bring mRNA Therapy to a Wider Audience
An EU research project has launched with the aim of bringing mRNA treatments to a…
November 8, 2019 - 4 minutes
This Biotech Uses Messenger RNA to Treat Lethal Lung Inflammation
Based close to Berlin, Germany, the biotech startup Pantherna Therapeutics is developing a messenger RNA…
August 2, 2019 - 4 minutes
BioNTech Raises Whopping €290M to Fund Personalized mRNA Vaccines for Cancer
In one of the biggest ever funding rounds in European biotech, the German company BioNTech…
July 9, 2019 - 3 minutes
Rapid Response mRNA Vaccine Facility Gets €30M Funding
An mRNA vaccine facility, run by the German biotech CureVac, has received a €30M development…
March 1, 2019 - 3 minutes
